| Dr William A Hinrichs, MD | |
|
7127 Babilonia St, Carlsbad, CA 92009-6509 | |
| (760) 438-9118 | |
| Not Available |
| Full Name | Dr William A Hinrichs |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 7127 Babilonia St, Carlsbad, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053305870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G23625 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William A Hinrichs, MD 7127 Babilonia St, Carlsbad, CA 92009-6509 Ph: (760) 438-9118 | Dr William A Hinrichs, MD 7127 Babilonia St, Carlsbad, CA 92009-6509 Ph: (760) 438-9118 |
News Archive
InspireMD, Inc., a leader in embolic protection systems (EPS), today announced that it has initiated a Voluntary Field Action (VFA) following recent reports of MGuard Prime EPS stent dislodgements.
Researchers at Mayo Clinic have narrowed the search for effective prostate cancer biomarkers (genetic variations that point to a specific disease or condition), identifying changes in the expression of genes of the whole genome closely correlated to prostate cancer development and progression.
Restoring tumor-specific immunity is a treatment strategy that works well in melanoma and lung cancer patients. Now a new study out of the OHSU Knight Cancer Institute is reviving hope that the approach also may help men with life-threatening prostate cancer.
Medtronic, Inc. today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI SureScan pacing system.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today that new preclinical data published in the online edition of Circulation Research suggests that microRNA-15 (miR-15) inhibits cardiomyogenesis, the process whereby new heart muscle cells are formed.
› Verified 8 days ago
Dr. Henry F. Showah, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6260 El Camino Real # 100, Carlsbad, CA 92009 Phone: 760-476-2953 Fax: 760-476-2963 | |
Dr. John Peter Serra, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6260 El Camino Real Ste 101, Carlsbad, CA 92009 Phone: 760-448-6650 | |
Kelsey J Burson, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1040 Carlsbad Village Dr Apt 438, Carlsbad, CA 92008 Phone: 916-214-0724 |